Assignee
CELLTECH R&D LTD
GB·51 granted patents·19 pending applications·1,557 citations·filing 1995–2010
Top patents by PatentIndex Score
70 records- 0198US7052906B1Synthetic transmembrane componentsCELLTECH R&D LTD·Filed 2000·Granted May 30, 2006·257 cites·10 claims
- 0298US6579983B15-cyano-2-aminopyrimidine derivativesCELLTECH R&D LTD·Filed 2000·Granted Jun 17, 2003·228 cites·5 claims
- 0397US7262050B2Humanised antibodiesCELLTECH R&D LTD·Filed 2003·Granted Aug 28, 2007·53 cites·7 claims
- 0496US6511663B1Tri- and tetra-valent monospecific antigen-binding proteinsCELLTECH R&D LTD·Filed 2000·Granted Jan 28, 2003·172 cites·8 claims
- 0595US7261892B2Methods for diagnosis and treatment of epithelial-derived cancersCELLTECH R&D LTD·Filed 2004·Granted Aug 28, 2007·53 cites·3 claims
- 0695US7244615B2Humanized antibodiesCELLTECH R&D LTD·Filed 2003·Granted Jul 17, 2007·30 cites·7 claims
- 0795US7241877B2Humanised antibodiesCELLTECH R&D LTD·Filed 2003·Granted Jul 10, 2007·32 cites·7 claims
- 0894US7244832B2Humanised antibodiesCELLTECH R&D LTD·Filed 2003·Granted Jul 17, 2007·32 cites·7 claims
- 0994US6600037B14,5-disubstituted-2-aminopyrimidinesCELLTECH R&D LTD·Filed 2000·Granted Jul 29, 2003·56 cites·2 claims
- 1093US6750325B1CD3 specific recombinant antibodyCELLTECH R&D LTD·Filed 1999·Granted Jun 15, 2004·118 cites·9 claims
- 1193US6518283B1Squaric acid derivativesCELLTECH R&D LTD·Filed 2000·Granted Feb 11, 2003·64 cites·22 claims
- 1292US7566771B1Humanised antibodiesCELLTECH R&D LTD·Filed 1995·Granted Jul 28, 2009·73 cites·19 claims
- 1392US6599908B1Fused polycyclic 2-aminopyrimidine derivativesCELLTECH R&D LTD·Filed 2000·Granted Jul 29, 2003·47 cites·11 claims
- 1488US7700740B2Antibodies to CD83CELLTECH R&D LTD·Filed 2007·Granted Apr 20, 2010·13 cites·4 claims
- 1587US6878718B2Phenylalanine enamide derivativesCELLTECH R&D LTD·Filed 2002·Granted Apr 12, 2005·17 cites·8 claims
- 1684US7531676B2LipidsCELLTECH R&D LTD·Filed 2005·Granted May 12, 2009·7 cites·19 claims
- 1784US6677339B2Phenylalanine derivativesCELLTECH R&D LTD·Filed 2001·Granted Jan 13, 2004·19 cites·10 claims
- 1883US6872719B1Phenylalanine enamide derivativesCELLTECH R&D LTD·Filed 2003·Granted Mar 29, 2005·18 cites·8 claims
- 1983US6552029B12-pyrimidineamine derivatives and processes for their preparationCELLTECH R&D LTD·Filed 1999·Granted Apr 22, 2003·58 cites·13 claims
- 2082US6835738B1Phenylalanine enamide derivativesCELLTECH R&D LTD·Filed 2003·Granted Dec 28, 2004·17 cites·6 claims
- 2180US7122556B2Phenylalanine enamide derivativesCELLTECH R&D LTD·Filed 2004·Granted Oct 17, 2006·9 cites·25 claims
- 2280US6610700B2Enamine derivativesCELLTECH R&D LTD·Filed 2001·Granted Aug 26, 2003·13 cites·11 claims
- 2379US6734286B2Interleukin-5 specific recombinant antibodiesCELLTECH R&D LTD·Filed 2001·Granted May 11, 2004·9 cites·7 claims
- 2478USRE39548EInterleukin-5 specific recombinant antibodiesCELLTECH R&D LTD·Filed 2001·Granted Apr 3, 2007·4 cites·7 claims
- 2576US7423047B2Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitorsCELLTECH R&D LTD·Filed 2003·Granted Sep 9, 2008·8 cites·18 claims
- 2676US6808901B1Production of chimeric antibodiesCELLTECH R&D LTD·Filed 1995·Granted Oct 26, 2004·34 cites·11 claims
- 2776US6780874B2Enamine derivativesCELLTECH R&D LTD·Filed 2003·Granted Aug 24, 2004·8 cites·20 claims
- 2872US6506881B1Anti-HMFG antibodies and processes for their productionCELLTECH R&D LTD·Filed 1995·Granted Jan 14, 2003·23 cites·3 claims
- 2971US7872103B2Modulating immune responsesCELLTECH R&D LTD·Filed 2010·Granted Jan 18, 2011·1 cites·4 claims
- 3070US2005136054A1Humanised antibodiesCELLTECH R&D LTD·Filed 2004·Application pending·0 cites
- 3170US2005123534A1Humanised antibodiesCELLTECH R&D LTD·Filed 2004·Application pending·0 cites
- 3270US2006029593A1Humanised antibodiesCELLTECH R&D LTD·Filed 2004·Application pending·0 cites
- 3367US7176215B2Bicyclic oxopyridine and oxopyrimidine derivativesCELLTECH R&D LTD·Filed 2002·Granted Feb 13, 2007·3 cites·15 claims
- 3467US6455539B2Squaric acid derivatesCELLTECH R&D LTD·Filed 2000·Granted Sep 24, 2002·4 cites·19 claims
- 3567US6403608B13-Substituted isoquinolin-1-yl derivativesCELLTECH R&D LTD·Filed 2001·Granted Jun 11, 2002·3 cites·19 claims
- 3666US6534513B1Phenylalkanoic acid derivativesCELLTECH R&D LTD·Filed 1999·Granted Mar 18, 2003·11 cites·9 claims
- 3764US2006073136A1Humanised antibodiesCELLTECH R&D LTD·Filed 2005·Application pending·0 cites
- 3864US2006073137A1Humanised antibodiesCELLTECH R&D LTD·Filed 2005·Application pending·0 cites
- 3963US7850968B2Manipulation of cytokine levels using CD83 gene productsCELLTECH R&D LTD·Filed 2009·Granted Dec 14, 2010·0 cites·30 claims
- 4063US2007059307A1Biological productsCELLTECH R&D LTD·Filed 2006·Application pending·0 cites
- 4162US7323464B2Pyridine and pyrimidine derivativesCELLTECH R&D LTD·Filed 2002·Granted Jan 29, 2008·3 cites·14 claims
- 4261US6555562B1Phenylalanine derivativesCELLTECH R&D LTD·Filed 1999·Granted Apr 29, 2003·13 cites·9 claims
- 4359US6583301B1LipidsCELLTECH R&D LTD·Filed 1999·Granted Jun 24, 2003·17 cites·43 claims
- 4459US6469025B13-substituted isoquinolin-1-yl derivativesCELLTECH R&D LTD·Filed 2001·Granted Oct 22, 2002·1 cites·27 claims
- 4559US2004024220A1LipidsCELLTECH R&D LTD·Filed 2003·Application pending·0 cites
- 4658US2004235876A14,5-Disubstituted-2-aminopyrimidinesCELLTECH R&D LTD·Filed 2004·Application pending·0 cites
- 4756US6953798B1β-alanine derivatesCELLTECH R&D LTD·Filed 1999·Granted Oct 11, 2005·13 cites·20 claims
- 4856US6911451B1Phenylalanine derivativesCELLTECH R&D LTD·Filed 1999·Granted Jun 28, 2005·12 cites·9 claims
- 4956US2005171134A14,5-Disubstituted-2-aminopyrimidinesCELLTECH R&D LTD·Filed 2005·Application pending·0 cites
- 5055US2005215598A1Phenylalanine derivativesCELLTECH R&D LTD·Filed 2005·Application pending·0 cites
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CELLTECH R&D LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →